Itay&Beyond is a pioneering biotech startup revolutionizing neuropsychiatric drug discovery through its groundbreaking platform. Founded by Dr. Nisim Perets, Shmulik Bezalel, and Boaz Goldman, and inspired by Bezalel's personal experience with autism, the company is driven by the urgent need for more effective treatments in neuropsychiatry.
Our technology, validated in a 200-patient study at Hadassah Medical Center, combines patient-derived brain organoids, a bio-dynamic processing unit, and advanced AI analysis to dramatically improve drug efficacy predictions. These 3-dimensional brain clones, derived from human stem cells, can perform 70,000 electrical signals per second, providing an unprecedented model for understanding drug effects. Our adaptable and scalable system reads functional outputs and monitors responses to various compounds over time, yielding precise predictions of drug efficacy for specific populations with neurological and psychiatric disorders.
Itay&Beyond's vision is to transform lives by breaking through barriers in neuropsychiatric drug discovery. By partnering with pharmaceutical companies and Contract Research Organizations (CROs), we offer programs for patient stratification, population expansion, drug repurposing, and new compound discovery. Our ability to predict drug efficacy before clinical trials accelerates the development of effective treatments, providing new hope for millions worldwide affected by these disorders.
Learn more: https://itayandbeyond.com/
Company Details
- Employees
- 15
- Founded
- -
- Address
- Jerusalem, 6745904, Il
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://itayandbeyond.com
- Keywords
- neuropsychiatry, neurological disorders, biotech, drug development, drug efficacy prediction, development of new medication, neuropsychiatric drug discovery, brain organoids, neuroscience, brain chip, brain on a chip, organoids, brain disorders, ai drug discovery, drug discovery, organoid intelligence, organ on chip, drug efficacy, biotechnology, biotech startup, joint drug development, research, brain research.
- HQ
- Jerusalem
Itay&beyond Questions
Itay&Beyond's website is http://itayandbeyond.com
Itay&Beyond's LinkedIn profile is https://il.linkedin.com/company/itayandbiond
Itay&Beyond has
15 employees.
View email and phone details for 15
employees at Itay&Beyond.
Itay&Beyond's industry is
Biotechnology Research
Itay&Beyond's top competitors are
Neurokaire (Formerly Genetika+),
Brainsway,
Nurexone Biologic (Otcqb:nrxbf) (Tsxv: Nrx) (Fse: J90),
Anima Biotech,
Cytoreason,
Pluri,
Nanosono,
Levenberg Lab,
Memed,
Emris Pharma.
Itay&Beyond's categories are Biotechnology Research
Itay&Beyond's founding year is 2021
